elranatamab-bcmm 76 MG in 1.9 ML Injection
- RxCUI
- 2644893
- RxNorm name
- elranatamab-bcmm 76 MG in 1.9 ML Injection
- Display name
- elranatamab-bcmm 76 MG in 1.9 ML Injection
- Full name
- elranatamab-bcmm 76 MG in 1.9 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761345 | Elrexfio | elranatamab-bcmm | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Elrexfio | ELRANATAMAB-BCMM | Pfizer Laboratories Div Pfizer Inc | f6fea598-ff58-4a20-b5e8-8a51f37d8beb | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 2644893 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f6fea598-ff58-4a20-b5e8-8a51f37d8beb | elranatamab-bcmm 76 MG in 1.9 ML Injection [PSN] · 1.9 ML elranatamab-bcmm 40 MG/ML Injection [SCD] · elranatamab-bcmm 76 MG per 1.9 ML Injection [SY] | 3 | 4 | These highlights do not include all the information needed to use ELREXFIO safely and effectively. See full prescribing information for ELREXFIO. ELREXFIO ® (elranatamab-bcmm) injection, for subcutaneous use Initial U.S. Approval: 2023 | 20260226 |